rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-7-3
|
pubmed:abstractText |
Hypertension in kidney transplant (KT) patients may result from attenuated whole-body nitric oxide (NO) content and abnormal NO-mediated vasodilation. Increasing NO bioavailability with L-arginine (ARG) could theoretically restore the NO-mediated vasodilatory response and lower blood pressure.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0148-6071
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
194-202
|
pubmed:dateRevised |
2007-2-21
|
pubmed:meshHeading |
pubmed-meshheading:11434650-Adult,
pubmed-meshheading:11434650-Arginine,
pubmed-meshheading:11434650-Blood Pressure,
pubmed-meshheading:11434650-Creatinine,
pubmed-meshheading:11434650-Cross-Over Studies,
pubmed-meshheading:11434650-Dietary Supplements,
pubmed-meshheading:11434650-Fatty Acids, Monounsaturated,
pubmed-meshheading:11434650-Female,
pubmed-meshheading:11434650-Humans,
pubmed-meshheading:11434650-Hypertension,
pubmed-meshheading:11434650-Kidney Diseases,
pubmed-meshheading:11434650-Kidney Transplantation,
pubmed-meshheading:11434650-Longitudinal Studies,
pubmed-meshheading:11434650-Male,
pubmed-meshheading:11434650-Middle Aged,
pubmed-meshheading:11434650-Nitrates,
pubmed-meshheading:11434650-Nitric Oxide,
pubmed-meshheading:11434650-Pilot Projects,
pubmed-meshheading:11434650-Prospective Studies,
pubmed-meshheading:11434650-Renal Dialysis,
pubmed-meshheading:11434650-Vasodilation
|
pubmed:articleTitle |
Oral arginine improves blood pressure in renal transplant and hemodialysis patients.
|
pubmed:affiliation |
Department of Surgery, University of Cincinnati, Ohio 45267-0558, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|